Immune Checkpoint Inhibitors and Lupus Erythematosus

• Главные авторы: Hans Vitzthum von Eckstaedt (Автор), Arohi Singh (Автор), Pankti Reid (Автор), Kimberly Trotter (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2024-02-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Immune checkpoint inhibitors (ICIs) are the standard of care for a growing number of malignancies. Unfortunately, they are associated with a broad range of unique toxicities that mimic the presentations of primary autoimmune conditions. These adverse events are termed immune-related adverse events (...